- Home
- IVDA vs RDHL Comparison
IVDA vs RDHL Comparison
Compare IVDA & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVDA
- RDHL
- Stock Information
- Founded
- IVDA 2003
- RDHL 2009
- Country
- IVDA United States
- RDHL Israel
- Employees
- IVDA N/A
- RDHL N/A
- Industry
- IVDA Computer Software: Prepackaged Software
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- IVDA Technology
- RDHL Health Care
- Exchange
- IVDA Nasdaq
- RDHL Nasdaq
- Market Cap
- IVDA 4.3M
- RDHL 3.9M
- IPO Year
- IVDA N/A
- RDHL N/A
- Fundamental
- Price
- IVDA $1.33
- RDHL $1.65
- Analyst Decision
- IVDA
- RDHL
- Analyst Count
- IVDA 0
- RDHL 0
- Target Price
- IVDA N/A
- RDHL N/A
- AVG Volume (30 Days)
- IVDA 5.1M
- RDHL 4.2M
- Earning Date
- IVDA 11-13-2025
- RDHL 09-05-2025
- Dividend Yield
- IVDA N/A
- RDHL N/A
- EPS Growth
- IVDA N/A
- RDHL N/A
- EPS
- IVDA N/A
- RDHL N/A
- Revenue
- IVDA $7,142,302.00
- RDHL $9,550,000.00
- Revenue This Year
- IVDA $340.48
- RDHL $381.91
- Revenue Next Year
- IVDA N/A
- RDHL N/A
- P/E Ratio
- IVDA N/A
- RDHL N/A
- Revenue Growth
- IVDA 88.96
- RDHL 157.62
- 52 Week Low
- IVDA $1.15
- RDHL $1.06
- 52 Week High
- IVDA $8.05
- RDHL $8.75
- Technical
- Relative Strength Index (RSI)
- IVDA 46.08
- RDHL 46.90
- Support Level
- IVDA $1.18
- RDHL $1.64
- Resistance Level
- IVDA $1.34
- RDHL $1.90
- Average True Range (ATR)
- IVDA 0.13
- RDHL 0.17
- MACD
- IVDA -0.01
- RDHL -0.02
- Stochastic Oscillator
- IVDA 30.86
- RDHL 23.44
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.